BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23274356)

  • 1. Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.
    Shvidel L; Tadmor T; Braester A; Bairey O; Rahimi-Levene N; Herishanu Y; Klepfish A; Shtalrid M; Berrebi A; Polliack A;
    Ann Hematol; 2013 May; 92(5):661-7. PubMed ID: 23274356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Kyasa MJ; Parrish RS; Schichman SA; Zent CS
    Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
    D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
    Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations.
    De Back TR; Kater AP; Tonino SH
    Expert Rev Hematol; 2018 Aug; 11(8):613-624. PubMed ID: 29923432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
    Rogers KA; Woyach JA
    Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications.
    Tadmor T; Shvidel L; Aviv A; Ruchlemer R; Bairey O; Yuklea M; Herishanu Y; Braester A; Rahimi-Levene N; Vernea F; Ben-Ezra J; Bejar J; Polliack A;
    Cancer; 2013 May; 119(10):1853-9. PubMed ID: 23423815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?
    Visco C; Cortelezzi A; Moretta F; Falisi E; Maura F; Finotto S; Barcellini W; Ambrosetti A; Neri A; Ruggeri M; Rodeghiero F
    Leuk Lymphoma; 2014 Jun; 55(6):1261-5. PubMed ID: 24047107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
    Diehl LF; Ketchum LH
    Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence and prognostic significance of autoimmune cytopenias in a cohort of Egyptian patients with chronic lymphocytic leukemia.
    Atef B; Azmy E; Aladle D; Mabed M
    Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):97-104. PubMed ID: 30802421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
    Quinquenel A; Willekens C; Dupuis J; Royer B; Ysebaert L; De Guibert S; Michallet AS; Feugier P; Guieze R; Levy V; Delmer A
    Am J Hematol; 2015 Mar; 90(3):204-7. PubMed ID: 25428829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia.
    Maura F; Visco C; Falisi E; Reda G; Fabris S; Agnelli L; Tuana G; Lionetti M; Guercini N; Novella E; Nichele I; Montaldi A; Autore F; Gregorini A; Barcellini W; Callea V; Mauro FR; Laurenti L; Foà R; Neri A; Rodeghiero F; Cortelezzi A
    Am J Hematol; 2013 Jan; 88(1):32-6. PubMed ID: 23115077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune cytopenia in chronic lymphocytic leukemia: diagnosis and treatment.
    Yevstakhevych YL; Vyhovska YI; Yevstakhevych IY; Vyhovska OY; Pelenyo NV; Semerak MM; Novak VL; Loginsky VE
    Exp Oncol; 2020 Dec; 42(4):318-323. PubMed ID: 33355861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-mediated hemolytic anemia and thrombocytopenia in clonal B-cell disorders: a review.
    Durani U; Go RS; Kay NE
    Clin Adv Hematol Oncol; 2018 Oct; 16(10):670-676. PubMed ID: 30543597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia in India--a clinico-hematological profile.
    Agrawal N; Naithani R; Mahapatra M; Panigrahi I; Kumar R; Pati HP; Saxena R; Choudhary VP
    Hematology; 2007 Jun; 12(3):229-33. PubMed ID: 17558698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface expression of CD25 antigen (surface IL-2 receptor α-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients.
    Shvidel L; Braester A; Bairey O; Rahimi-Levene N; Herishanu Y; Tadmor T; Klepfish A; Ruchlemer R; Shtalrid M; Berrebi A; Polliack A;
    Ann Hematol; 2012 Oct; 91(10):1597-602. PubMed ID: 22623161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
    Carli G; Visco C; Falisi E; Perbellini O; Novella E; Giaretta I; Ferrarini I; Sandini A; Alghisi A; Ambrosetti A; Rodeghiero F
    Ann Hematol; 2016 May; 95(6):863-70. PubMed ID: 27001309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells CD19+ in patients with B-cell chronic lymphocytic leukaemia and autoimmune haemolytic anaemia.
    Słomkowski M; Kopeć-Szlezak J; Fabijańska-Mitek J; Podstawka U; Sikorska A; Mendek-Czajkowska E
    Clin Lab Haematol; 2004 Dec; 26(6):385-9. PubMed ID: 15595995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old DAT and new data: positive direct antiglobulin test identifies a subgroup with poor outcome among chronic lymphocytic leukemia stage A patients.
    Quinquenel A; Al Nawakil C; Baran-Marszak F; Eclache V; Letestu R; Khalloufi M; Boubaya M; Le Roy C; Varin-Blank N; Delmer A; Levy V; Ajchenbaum-Cymbalista F
    Am J Hematol; 2015 Jan; 90(1):E5-8. PubMed ID: 25263543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients.
    Zanotti R; Frattini F; Ghia P; Visco C; Zamò A; Perbellini O; Stella S; Facco M; Giaretta I; Chilosi M; Pizzolo G; Ambrosetti A
    Am J Hematol; 2010 Jul; 85(7):494-8. PubMed ID: 20575031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.